IL6 and cancer: To further characterize the degree of these immunological differences, we also compared parameter distributions between the cancer and immunosuppressed VPCs and found a statistically significant difference in only one parameter (pMφI,L, the monocyte-to-macrophage differentiation by IL-6) between mild patients (S9 Fig) and no statistical differences between severe patients in those two VPCs (S10 Fig).